BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Advanced Therapies Wales - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Advanced Therapies Wales
X-ORIGINAL-URL:https://advancedtherapieswales.co.uk
X-WR-CALDESC:Events for Advanced Therapies Wales
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260826T160000
DTEND;TZID=Europe/London:20260826T163000
DTSTAMP:20260804T113642Z
CREATED:20260804T113642Z
LAST-MODIFIED:20260804T113642Z
UID:728-1787760000-1787761800@advancedtherapieswales.co.uk
SUMMARY:High-yield continuous lentiviral vector bioprocessing through perfusion intensification and integrated cold chain affinity capture
DESCRIPTION:Perfusion intensification\, cold harvest stabilization\, and inline affinity capture together can more than double lentiviral vector (LVV) recovery while removing steps from the process. This session presents a continuous LVV workflow that reached around 12 × 10⁶ viable cells/mL before transfection and delivered roughly 16-fold higher cumulative transduction units over 3 days through cold harvest handling. \nKeen Chung\, Technical Lead for Viral Vector Culture and Analytics at Repligen\, will show how coupling affinity capture directly to the perfusion permeate eliminates clarification and bulk harvest storage\, cutting hold times\, contamination risk\, and product loss. \nAttend this webinar to: \n\nApply a perfusion intensification approach that reached around 12 × 10⁶ viable cells/mL before transfection\, roughly 4-fold higher cell density\, to raise vector yield and cell-specific productivity\nQuantify how continuous cold harvest at 4°C delivered around 16-fold higher cumulative transduction units over 3 days\, informed by an LVV infectivity half-life of around 6 h at 37°C versus around 300h at 4°C\nSee how affinity capture coupled directly to the permeate enables continuous\, hold-free purification and removes clarification and bulk storage as separate unit operations\n\nCompare overall recovery against a conventional depth filtration and anion exchange chromatography route (around 25%)\, which the integrated process improved more than 2.5-fold \n  \nFind out more
URL:https://advancedtherapieswales.co.uk/event/high-yield-continuous-lentiviral-vector-bioprocessing-through-perfusion-intensification-and-integrated-cold-chain-affinity-capture/
LOCATION:Online
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://advancedtherapieswales.co.uk/wp-content/uploads/2026/08/Repligen-webinar-web.png
END:VEVENT
END:VCALENDAR